Navigation Links
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
Date:10/4/2011

FRANKLIN LAKES, N.J., Oct. 4, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2011 earnings conference call on Wednesday, November 2, 2011, at 8:00 a.m. (ET).  BD will issue a press release detailing the quarter's earnings earlier that morning.

The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for replay through Wednesday, November 9, 2011.    

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Monique N. Dolecki, Investor Relations – 201-847-5378
Colleen T. White, Corporate Communications – 201-847-5369


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Calif. , May 25, 2016  Zymo ... testing for their new reference materials that help ... from sample collection to analyses. The rapid growth ... demand for researchers to have standard methods to ... being generated. Biases inherently exist at every step ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... Blood Pressure products . , High blood pressure affects millions of people ... high blood pressure can lead to heart disease, stroke, kidney disease, and hardening ...
(Date:5/26/2016)... , ... May 26, 2016 , ... HealthPostures, ergonomics designer ... chair , furniture that may support women during pregnancy. Potential benefits of using the ... improved rest and comfort and healthier levels of sitting and standing. , Need for ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie is a great option ... and save. For a limited time only (offer expires May 31, 2016) customers can ... one, by using the promo code "Memorial" at checkout. The more Bunion Booties purchased, ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The 12th ... 6pm to 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech ... be led by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract ...
(Date:5/25/2016)... Chicago, IL (PRWEB) , ... May 25, 2016 ... ... HealthScape Advisors,” said Steven Young, a Managing Partner at HealthScape Advisors. “Brad brings ... value-based care within the healthcare delivery system accelerates with the implementation of MACRA, ...
Breaking Medicine News(10 mins):